Federico Ferrari

Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study

2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové

Publication